<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sammut SJ</submitter><funding>European Research Council</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><funding>Academy of Medical Sciences</funding><pagination>916-924</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11065701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(5)</volume><pubmed_abstract>B cells and T cells are important components of the adaptive immune system and mediate anticancer immunity. The T cell landscape in cancer is well characterized, but the contribution of B cells to anticancer immunosurveillance is less well explored. Here we show an integrative analysis of the B cell and T cell receptor repertoire from individuals with metastatic breast cancer and individuals with early breast cancer during neoadjuvant therapy. Using immune receptor, RNA and whole-exome sequencing, we show that both B cell and T cell responses seem to coevolve with the metastatic cancer genomes and mirror tumor mutational and neoantigen architecture. B cell clones associated with metastatic immunosurveillance and temporal persistence were more expanded and distinct from site-specific clones</pubmed_abstract><journal>Nature immunology</journal><pubmed_title>Predictability of B cell clonal persistence and immunosurveillance in breast cancer.</pubmed_title><pmcid>PMC11065701</pmcid><funding_grant_id>694620</funding_grant_id><funding_grant_id>MC_UU_00002/16</funding_grant_id><funding_grant_id>SGL028\1074</funding_grant_id><funding_grant_id>NF-SI-0515-10090</funding_grant_id><funding_grant_id>CL-2021-13-002</funding_grant_id><pubmed_authors>Schatzle S</pubmed_authors><pubmed_authors>Galson JD</pubmed_authors><pubmed_authors>De Mattos-Arruda L</pubmed_authors><pubmed_authors>Sammut SJ</pubmed_authors><pubmed_authors>Sun B</pubmed_authors><pubmed_authors>Seoane J</pubmed_authors><pubmed_authors>Caldas C</pubmed_authors><pubmed_authors>Finch DK</pubmed_authors><pubmed_authors>Minter R</pubmed_authors><pubmed_authors>Osbourn J</pubmed_authors><pubmed_authors>Bashford-Rogers RJM</pubmed_authors><pubmed_authors>Chin SF</pubmed_authors><pubmed_authors>Dias J</pubmed_authors><pubmed_authors>Rueda OM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictability of B cell clonal persistence and immunosurveillance in breast cancer.</name><description>B cells and T cells are important components of the adaptive immune system and mediate anticancer immunity. The T cell landscape in cancer is well characterized, but the contribution of B cells to anticancer immunosurveillance is less well explored. Here we show an integrative analysis of the B cell and T cell receptor repertoire from individuals with metastatic breast cancer and individuals with early breast cancer during neoadjuvant therapy. Using immune receptor, RNA and whole-exome sequencing, we show that both B cell and T cell responses seem to coevolve with the metastatic cancer genomes and mirror tumor mutational and neoantigen architecture. B cell clones associated with metastatic immunosurveillance and temporal persistence were more expanded and distinct from site-specific clones</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-01T05:37:14.656Z</modification><creation>2026-04-08T09:39:51.985Z</creation></dates><accession>S-EPMC11065701</accession><cross_references><pubmed>38698238</pubmed><doi>10.1038/s41590-024-01821-0</doi></cross_references></HashMap>